MetaLabs, MetaCare 4,878,049additional share acquisition and 60billion won paid-in capital increase
MetaLabs[090370] announced that it would additionally acquire 6 in 9 shares of its subsidiary MetaCare 4,878,049 shares for approximately 60 billion won, and decided on a 60-billion-won third-party allotment paid-in capital increase to raise funds for the acquisition of securities in other corporations and other purposes.3.

MetaLabs[090370] announced 6 in 9 two disclosures. The company disclosed details of transactions related to its subsidiary on the same day. The disclosures respectively concern investment and financing.
MetaLabs announced that it would additionally acquire 4,878,049 shares of its subsidiary MetaCare for approximately 60 billion won. MetaCare was identified as a subsidiary engaged in supplying pharmaceuticals and medical devices. The disclosure specifies the number of shares acquired and the amount.
On the same day, MetaLabs announced that it had decided on a 60-party allotment paid-in capital increase to raise 3 billion won for the acquisition of securities in other corporations and other purposes. The subscriber for the 3-party allotment was listed as MetaYakpum Co., Ltd. The disclosure states that the purpose of the paid-in capital increase is the acquisition of securities in other corporations and other purposes.
Both disclosures were registered on 6month 9dated. Each disclosure was posted as a separate item in the disclosure documents. Through the disclosures, the company announced the key details of the acquisition quantity and funding plan.
Investors can check the acquisition size and the designation of the recipients of the paid-in capital increase presented in Metlabs' disclosure. The company's stated details have been organized in accordance with the original disclosure. The relevant terms and conditions can be confirmed through the disclosure documents.
Sources: 연합뉴스 경제
Bullstory synthesized this report from the linked sources. AI may have assisted the writing process. Check the original reports for factual confirmation.